Cover Image
市場調查報告書

β聚葡萄糖的全球市場預測 2022年:穀類、海藻、酵母、蘑菇類

Beta-Glucan Market by Source (Cereal, Mushroom, Yeast, Seaweed), Application (Food & Beverages, Personal Care, Pharmaceuticals, Animal Feed), Category (Soluble, Insoluble), and Region - Global Forecast to 2022

出版商 MarketsandMarkets 商品編碼 482436
出版日期 內容資訊 英文 129 Pages
訂單完成後即時交付
價格
Back to Top
β聚葡萄糖的全球市場預測 2022年:穀類、海藻、酵母、蘑菇類 Beta-Glucan Market by Source (Cereal, Mushroom, Yeast, Seaweed), Application (Food & Beverages, Personal Care, Pharmaceuticals, Animal Feed), Category (Soluble, Insoluble), and Region - Global Forecast to 2022
出版日期: 2017年03月24日 內容資訊: 英文 129 Pages
簡介

全球β聚葡萄糖市場,預計從2016年的3億780萬美元以7.57%的年複合成長率發展,到2022年達到4億7,650萬美元的規模。該市場由於主要消費者的健康意識的高漲及醫療費的上升等要素所促進。抑制β聚葡萄糖市場成長的主要因素之一,是管轄β聚葡萄糖的法規標準的不一致。

本報告提供全球β聚葡萄糖市場相關分析,市場基本結構和最新形勢,主要市場促進、阻礙因素,市場趨勢與今後的預測,各來源、用途、分類、地區的詳細趨勢,市場競爭的狀態,及主要企業簡介等調查、考察。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • β聚葡萄糖廠商的市場機會
  • β聚葡萄糖市場規模:各來源
  • 北美的β聚葡萄糖市場:各國家、用途
  • β聚葡萄糖市場:各主要國家
  • β聚葡萄糖市場:各用途
  • β聚葡萄糖市場魅力

第5章 市場概要

  • 簡介
  • 市場考察
  • 市場動態
    • 成長推動因素
    • 成長阻礙因素
    • 市場機會
    • 課題
  • 供應鏈
    • 有潛力的企業
    • 中小企業
    • 終端用戶 (廠商/消費者)

第6章 β聚葡萄糖市場:各來源

  • 簡介
  • 穀類
  • 海藻
  • 酵母
  • 蘑菇

第7章 β聚葡萄糖市場:各用途

  • 簡介
  • 食品和飲料
  • 個人保養品
  • 醫藥品
  • 動物用飼料

第8章 β聚葡萄糖市場:各分類

  • 簡介
  • 溶解性β聚葡萄糖
  • 不溶性β聚葡萄糖

第9章 β聚葡萄糖市場:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 澳洲 & 紐西蘭
    • 其他
  • 其他 (RoW)
    • 南美
    • 中東
    • 其他

第10章 食品用氨基酸市場:各品牌

  • 簡介
  • OatWell
  • PromOat
  • Glucagel
  • SANACEL
  • avenacare
  • Nutrim
  • wellmune
  • Yestimun

第11章 β聚葡萄糖市場:各開採方法

  • 簡介
  • 來自穀類的β聚葡萄糖
  • 來自酵母的β聚葡萄糖

第12章 β聚葡萄糖市場:營運組織

  • 簡介
  • 北美
  • 歐洲食品安全機關 (EFSA)
  • EU

第13章 競爭環境

  • 概要
  • 排行榜分析
  • 競爭情形、趨勢
  • 收購
  • 擴大、投資
  • 新產品銷售

第14章 企業簡介

  • 簡介
  • CARGILL, INC
  • TATE & LYLE PLC
  • KERRY GROUP PLC
  • KONINKLIJKE DSM N.V.
  • FRUTAROM
  • GARUDA INTERNATIONAL INC.
  • OHLY
  • MILLIPORESIGMA
  • SUPER BETA GLUCAN
  • LESAFFRE HUMAN CARE

第15章 附錄

目錄
Product Code: FB 5113

"The beta-glucan market is projected to grow at a CAGR of 7.57%"

The beta-glucan market was valued at USD 307.8 million in 2016, and is expected to grow at a CAGR of 7.57%, to reach USD 476.5 million by 2022. The market is primarily driven by factors such as growing health consciousness among consumers and the increasing health expenditure. North America is projected to be the fastest-growing region as the consumers in are gradually becoming aware of the health benefits of oat beta-glucan and its significance in enhancing the body's immunity. One of the major restraints in the growth of the beta-glucan market is the inconsistency in regulatory norms governing beta-glucan.

"Cereal as a source of beta-glucan led the market with the largest share in 2016"

On the basis of source, the beta-glucan market was led by the cereal segment, followed by yeast. Cereal is sourced mainly from oats and barley as they contain the highest amount of beta-glucan.

"Soluble beta-glucan led the market, in terms of value, with the largest share in 2016"

On the basis of category, the beta-glucan market was led by the soluble segment, followed by insoluble beta-glucan. Products containing soluble beta-glucan are fortified with food to act against diseases such as coronary heart disease, diabetes, and obesity, which are predominant in developed countries. Insoluble beta-glucan is fibrous, which is vital for a healthy digestive system.

"Pharmaceuticals segment is projected to be the fastest-growing application"

The pharmaceuticals application of beta-glucan dominates the market due to its ability to cure problems such as obesity, blood pressure, and diabetes. With the increase in the quality and the arrival of clinically proven products in the market, the trust of consumers is growing for these products. The growing market for functional food & beverages is presenting opportunities for the application of beta-glucan in the food & beverage industry.

"North America: High growth is expected in the beta-glucan market"

North America is projected to be the fastest-growing market for the period considered for this study as the beta-glucan market here is led by its broad applications in various products, along with their health benefits. The North American region is majorly driven by the U.S. market and the increasing incidences of diseases and widespread application of fibers & specialty ingredients in various food products, beverages, and dietary supplements.

Break-up of Primaries:

  • By Company Type: Tier 1 - 45 %, Tier 2 - 30%, and Tier 3 - 25%
  • By Designation: Director Level: - 15%, C Level - 50%, and Others - 35%
  • By Region: North America - 55%, Europe - 20%, Asia-Pacific -20%, and RoW - 5%

Leading players profiled in this report:

  • Cargill (U.S.)
  • Kerry Group plc (Israel)
  • Tate & Lyle (U.K.)
  • Royal DSM (Netherlands)
  • Ohly (Germany)
  • Frutarom (Israel)
  • MilliporeSigma (U.S.)
  • Super Beta Glucan (U.S.)
  • Garuda International (U.S.)
  • Lesaffre Human Care (France)

Research Coverage:

The report segments the beta-glucan market on the basis of category, source, application, and region. In terms of insights, this research report has focused on various levels of analyses-competitive landscape, end-use analysis, and company profiles, which together comprise and discuss the basic views on the emerging & high-growth segments of the global beta-glucan market, high-growth regions, countries, government initiatives, drivers, restraints, opportunities, and challenges.

Reasons to Buy the Report:

  • To get a comprehensive overview of the beta-glucan market
  • To gain information about the top players in this industry, their product portfolios, and key strategies
  • To gain insights about the major countries/regions in which the beta-glucan market is flourishing

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. STUDY SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. PERIODIZATION CONSIDERED
  • 1.4. CURRENCY
  • 1.5. UNITS
  • 1.6. STAKEHOLDERS
  • 1.7. LIMITATIONS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key industry insights
      • 2.1.2.2. Breakdown of primaries, by company type, designation, and region
  • 2.2. MARKET BREAKDOWN & DATA TRIANGULATION
  • 2.3. MARKET SIZE ESTIMATION
    • 2.3.1. BOTTOM-UP APPROACH
    • 2.3.2. TOP-DOWN APPROACH
  • 2.4. MACROINDICATORS
    • 2.4.1. INCREASE IN HEALTH PROBLEMS AND DISEASES
      • 2.4.1.1. Diabetes, cancer, and cardiovascular diseases
      • 2.4.1.2. HIV/AIDS
    • 2.4.2. CONSUMPTION OF DIETARY FIBER
  • 2.5. RESEARCH ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. MARKET OPPORTUNITIES FOR BETA-GLUCAN MANUFACTURERS
  • 4.2. BETA-GLUCAN MARKET SIZE, BY SOURCE
  • 4.3. NORTH AMERICA: BETA-GLUCAN MARKET, BY COUNTRY AND APPLICATION
  • 4.4. BETA-GLUCAN MARKET, TOP COUNTRIES
  • 4.5. BETA-GLUCAN MARKET, BY APPLICATION
  • 4.6. BETA-GLUCAN MARKET ATTRACTIVENESS

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET INSIGHTS
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Growing health consciousness among consumers and increasing health expenditure
      • 5.3.1.2. Growing application of beta-glucan in different industries
      • 5.3.1.3. Decreasing prices of major raw material sources
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. Inconsistency in regulatory norms governing beta-glucan
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Untapped beta-glucan applications
      • 5.3.3.2. Emerging markets: New growth frontiers
    • 5.3.4. CHALLENGES
      • 5.3.4.1. High cost of beta-glucan extraction
  • 5.4. SUPPLY CHAIN
    • 5.4.1. PROMINENT COMPANIES
    • 5.4.2. SMALL & MEDIUM ENTERPRISES
    • 5.4.3. END USERS (MANUFACTURERS/CONSUMERS)

6. BETA-GLUCAN MARKET, BY SOURCE

  • 6.1. INTRODUCTION
  • 6.2. CEREAL
  • 6.3. SEAWEED
  • 6.4. YEAST
  • 6.5. MUSHROOM

7. BETA-GLUCAN MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. FOOD & BEVERAGES
  • 7.3. PERSONAL CARE
  • 7.4. PHARMACEUTICALS
  • 7.5. ANIMAL FEED

8. BETA-GLUCAN MARKET, BY CATEGORY

  • 8.1. INTRODUCTION
  • 8.2. SOLUBLE BETA-GLUCAN
  • 8.3. INSOLUBLE BETA-GLUCAN

9. BETA-GLUCAN MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
    • 9.2.2. CANADA
    • 9.2.3. MEXICO
  • 9.3. EUROPE
    • 9.3.1. GERMANY
    • 9.3.2. FRANCE
    • 9.3.3. U.K.
    • 9.3.4. ITALY
    • 9.3.5. SPAIN
    • 9.3.6. REST OF EUROPE
  • 9.4. ASIA-PACIFIC
    • 9.4.1. CHINA
    • 9.4.2. INDIA
    • 9.4.3. AUSTRALIA & NEW ZEALAND
    • 9.4.4. REST OF ASIA-PACIFIC
  • 9.5. REST OF THE WORLD (ROW)
    • 9.5.1. LATIN AMERICA
    • 9.5.2. MIDDLE EAST
    • 9.5.3. OTHERS IN ROW

10. BETA-GLUCAN MARKET, BY BRAND (QUALITATIVE CHAPTER)

  • 10.1. INTRODUCTION
  • 10.2. OATWELL
  • 10.3. PROMOAT
  • 10.4. GLUCAGEL
  • 10.5. SANACEL
  • 10.6. AVENACARE
  • 10.7. NUTRIM
  • 10.8. WELLMUNE
  • 10.9. YESTIMUN

11. BETA-GLUCAN MARKET, BY EXTRACTION METHOD (QUALITATIVE CHAPTER)

  • 11.1. INTRODUCTION
  • 11.2. BETA-GLUCAN FROM CEREAL
  • 11.3. BETA-GLUCAN FROM YEAST

12. BETA-GLUCAN MARKET, GOVERNING ORGANIZATIONS

  • 12.1. INTRODUCTION
  • 12.2. NORTH AMERICA
    • 12.2.1. U.S. FOOD AND DRUG ADMINISTRATION (21CFR101.14)
    • 12.2.2. U.S. FOOD AND DRUG ADMINISTRATION (21CFR101.81)
  • 12.3. EUROPEAN FOOD SAFETY AUTHORITY
  • 12.4. EUROPEAN UNION

13. COMPETITIVE LANDSCAPE

  • 13.1. OVERVIEW
  • 13.2. RANKING ANALYSIS
  • 13.3. COMPETITIVE SITUATIONS & TRENDS
  • 13.4. ACQUISITIONS
  • 13.5. EXPANSIONS & INVESTMENTS
  • 13.6. NEW PRODUCT LAUNCHES

14. COMPANY PROFILES (Company at a Glance, Recent Financials, Products & Services, Strategies & Insights, & Recent Developments)*

  • 14.1. INTRODUCTION
  • 14.2. CARGILL, INC
  • 14.3. TATE & LYLE PLC
  • 14.4. KERRY GROUP PLC
  • 14.5. KONINKLIJKE DSM N.V.
  • 14.6. FRUTAROM
  • 14.7. GARUDA INTERNATIONAL INC.
  • 14.8. OHLY
  • 14.9. MILLIPORESIGMA
  • 14.10. SUPER BETA GLUCAN
  • 14.11. LESAFFRE HUMAN CARE

*Details on company at a glance, recent financials, products & services, strategies & insights, & recent developments might not be captured in case of unlisted companies.

15. APPENDIX

  • 15.1. DISCUSSION GUIDE
  • 15.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 15.4. AVAILABLE CUSTOMIZATIONS
  • 15.5. RELATED REPORTS
  • 15.6. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT
  • TABLE 2: BETA-GLUCAN MARKET SIZE, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 3: BETA-GLUCAN MARKET SIZE, BY SOURCE, 2015-2022 (KT)
  • TABLE 4: CEREAL MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 5: CEREAL MARKET SIZE, BY REGION, 2015-2022 (KT)
  • TABLE 6: SEAWEED MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 7: SEAWEED MARKET SIZE, BY REGION, 2015-2022 (KT)
  • TABLE 8: YEAST MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 9: YEAST MARKET SIZE, BY REGION, 2015-2022 (KT)
  • TABLE 10: MUSHROOM MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 11: MUSHROOM MARKET SIZE, BY REGION, 2015-2022 (KT)
  • TABLE 12: APPLICATION OVERVIEW
  • TABLE 13: BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 14: BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2015-2022 (KT)
  • TABLE 15: BETA-GLUCAN MARKET SIZE FOR FOOD & BEVERAGES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 16: BETA-GLUCAN MARKET SIZE FOR FOOD & BEVERAGES, BY REGION, 2015-2022 (KT)
  • TABLE 17: BETA-GLUCAN MARKET SIZE FOR PERSONAL CARE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 18: BETA-GLUCAN MARKET SIZE FOR PERSONAL CARE, BY REGION, 2015-2022 (KT)
  • TABLE 19: BETA-GLUCAN MARKET SIZE FOR PHARMACEUTICALS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 20: BETA-GLUCAN MARKET SIZE FOR PHARMACEUTICALS, BY REGION, 2015-2022 (KT)
  • TABLE 21: BETA-GLUCAN MARKET SIZE FOR ANIMAL FEED, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 22: BETA-GLUCAN MARKET SIZE FOR ANIMAL FEED, BY REGION, 2015-2022 (KT)
  • TABLE 23: BETA-GLUCAN MARKET SIZE, BY CATEGORY, 2015-2022 (USD MILLION)
  • TABLE 24: BETA-GLUCAN MARKET SIZE, BY CATEGORY, 2015-2022 (KT)
  • TABLE 25: SOLUBLE BETA-GLUCAN MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 26: SOLUBLE BETA-GLUCAN MARKET SIZE, BY REGION, 2015-2022 (KT)
  • TABLE 27: INSOLUBLE BETA-GLUCAN MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 28: INSOLUBLE BETA-GLUCAN MARKET SIZE, BY REGION, 2015-2022 (KT)
  • TABLE 29: BETA-GLUCAN MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 30: BETA-GLUCAN MARKET SIZE, BY REGION, 2015-2022 (KT)
  • TABLE 31: NORTH AMERICA: BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 32: NORTH AMERICA: BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2015-2022 (KT)
  • TABLE 33: NORTH AMERICA: BETA-GLUCAN MARKET SIZE, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 34: NORTH AMERICA: BETA-GLUCAN MARKET SIZE, BY SOURCE, 2015-2022 (KT)
  • TABLE 35: NORTH AMERICA: BETA-GLUCAN MARKET SIZE, BY CATEGORY, 2015-2022 (USD MILLION)
  • TABLE 36: NORTH AMERICA: BETA-GLUCAN MARKET SIZE, BY CATEGORY, 2015-2022 (KT)
  • TABLE 37: NORTH AMERICA: BETA-GLUCAN MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 38: EUROPE: BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 39: EUROPE: BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2015-2022 (KT)
  • TABLE 40: EUROPE: BETA-GLUCAN MARKET SIZE, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 41: EUROPE: BETA-GLUCAN MARKET SIZE, BY SOURCE, 2015-2022 (KT)
  • TABLE 42: EUROPE: BETA-GLUCAN MARKET SIZE, BY CATEGORY, 2015-2022 (USD MILLION)
  • TABLE 43: EUROPE: BETA-GLUCAN MARKET SIZE, BY CATEGORY, 2015-2022 (KT)
  • TABLE 44: EUROPE: BETA GLUCAN MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 45: EUROPE: BETA-GLUCAN MARKET SIZE, BY COUNTRY, 2015-2022 (KT)
  • TABLE 46: ASIA-PACIFIC: BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 47: ASIA-PACIFIC: BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2015-2022 (KT)
  • TABLE 48: ASIA-PACIFIC: BETA-GLUCAN MARKET SIZE, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 49: ASIA-PACIFIC: BETA-GLUCAN MARKET SIZE, BY SOURCE, 2015-2022 (KT)
  • TABLE 50: ASIA-PACIFIC: BETA-GLUCAN MARKET SIZE, BY CATEGORY, 2015-2022 (USD MILLION)
  • TABLE 51: ASIA-PACIFIC: BETA GLUCAN MARKET SIZE, BY CATEGORY, 2015-2022 (KT)
  • TABLE 52: ASIA-PACIFIC: BETA-GLUCAN MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 53: ASIA-PACIFIC: BETA-GLUCAN MARKET SIZE, BY COUNTRY, 2015-2022 (KT)
  • TABLE 54: ROW: BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 55: ROW: BETA-GLUCAN MARKET SIZE, BY APPLICATION, 2015-2022 (KT)
  • TABLE 56: ROW: BETA-GLUCAN MARKET SIZE, BY SOURCE, 2015-2022 (USD MILLION)
  • TABLE 57: ROW: BETA-GLUCAN MARKET SIZE, BY SOURCE, 2015-2022 (KT)
  • TABLE 58: ROW: BETA-GLUCAN MARKET SIZE, BY CATEGORY, 2015-2022 (USD MILLION)
  • TABLE 59: ROW: BETA-GLUCAN MARKET SIZE, BY CATEGORY, 2015-2022 (KT)
  • TABLE 60: ROW: BETA-GLUCAN MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 61: ROW: BETA-GLUCAN MARKET SIZE, BY REGION, 2015-2022 (KT)
  • TABLE 62: BETA-GLUCAN YIELDS AND PRODUCTION TECHNOLOGIES FROM VARIOUS SOURCES
  • TABLE 63: ACQUISITIONS
  • TABLE 64: EXPANSIONS & INVESTMENTS
  • TABLE 65: NEW PRODUCT LAUNCHES

LIST OF FIGURES

  • FIGURE 1: BETA-GLUCAN MARKET SEGMENTATION
  • FIGURE 2: BETA-GLUCAN MARKET: RESEARCH DESIGN
  • FIGURE 3: DATA TRIANGULATION & METHODOLOGY
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 6: GLOBAL NUMBER OF NEW CANCER CASES FOR ALL AGES (MILLION)
  • FIGURE 7: NUMBER OF PEOPLE LIVING WITH HIV AND ACCESSING TREATMENT, 2011-2015 (MILLION)
  • FIGURE 8: FIBER INTAKE (G/DAY), BY COUNTRY
  • FIGURE 9: ASSUMPTIONS OF THE RESEARCH STUDY
  • FIGURE 10: FOOD & BEVERAGES SEGMENT IS EXPECTED TO BE THE FASTEST-GROWING APPLICATION DURING THE FORECAST PERIOD
  • FIGURE 11: BETA-GLUCAN MARKET SNAPSHOT (2017 VS. 2022): CEREAL SEGMENT IS PROJECTED TO BE THE LARGEST
  • FIGURE 12: U.S. ESTIMATED TO DOMINATE THE BETA-GLUCAN MARKET IN 2017
  • FIGURE 13: ATTRACTIVE GROWTH OPPORTUNITIES IN THE BETA-GLUCAN MARKET FOR FOOD & BEVERAGE MANUFACTURERS BETWEEN 2017 AND 2022
  • FIGURE 14: CEREAL-SOURCED BETA-GLUCAN TO GROW AT THE HIGHEST RATE FROM 2017 TO 2022
  • FIGURE 15: U.S. ACCOUNTED FOR THE LARGEST SHARE IN THE BETA-GLUCAN MARKET IN 2016
  • FIGURE 16: U.S. BETA-GLUCAN MARKET TO GROW AT THE HIGHEST RATE FROM 2017 TO 2022, IN TERMS OF VALUE
  • FIGURE 17: PHARMACEUTICALS SEGMENT DOMINATED ACROSS ALL REGIONS
  • FIGURE 18: EUROPE TO ACCOUNT FOR THE LARGEST SHARE, WHEREAS NORTH AMERICA TO GROW AT THE HIGHEST RATE
  • FIGURE 19: BETA-GLUCAN MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 20: INCREASING PER CAPITA HEALTH EXPENDITURE IN MAJOR ECONOMIES, 2010-2014
  • FIGURE 21: INDUSTRY INDEXES OF MAJOR FOOD & BEVERAGE AND PHARMACEUTICAL & HEALTHCARE COMPANIES (2012-2016)
  • FIGURE 22: YEARLY AVERAGE PRICES (USD/MT) OF WHEAT, BARLEY, AND SORGHUM (2012-2016)
  • FIGURE 23: SUPPLY CHAIN: BETA-GLUCAN MARKET
  • FIGURE 24: REGIONAL SNAPSHOT: NORTH AMERICA TO BE THE MOST ATTRACTIVE MARKET FOR BETA-GLUCAN MANUFACTURERS, 2017-2022
  • FIGURE 25: NORTH AMERICAN BETA-GLUCAN MARKET: A SNAPSHOT
  • FIGURE 26: EUROPEAN BETA-GLUCAN MARKET: A SNAPSHOT
  • FIGURE 27: ACQUISITIONS AND EXPANSIONS: LEADING APPROACHES OF KEY COMPANIES, 2011-2016
  • FIGURE 28: EXPANDING REVENUE BASE THROUGH ACQUISITIONS, 2014-2016
  • FIGURE 29: CARGILL, INC: COMPANY SNAPSHOT
  • FIGURE 30: CARGILL INC.: SWOT ANALYSIS
  • FIGURE 31: TATE & LYLE PLC: COMPANY SNAPSHOT
  • FIGURE 32: TATE & LYLE PLC: SWOT ANALYSIS
  • FIGURE 33: KERRY GROUP PLC: COMPANY SNAPSHOT
  • FIGURE 34: KERRY GROUP PLC: SWOT ANALYSIS
  • FIGURE 35: KONINKLIJKE DSM N.V: COMPANY SNAPSHOT
  • FIGURE 36: KONINKLIJKE DSM N.V.: SWOT ANALYSIS
  • FIGURE 37: FRUTAROM: COMPANY SNAPSHOT
  • FIGURE 38: FRUTAROM: SWOT ANALYSIS
  • FIGURE 39: MILLIPORESIGMA: COMPANY SNAPSHOT
Back to Top